Cancer Biology and Inflammatory Disorder Division, Council of Scientific & Industrial Research-Indian Institute of Chemical Biology, Kolkata 700032, West Bengal, India,
Postharvest Technology Laboratory, Indian Council of Agricultural Research-National Research Centre on Pomegranate, Solapur 413255, Maharashtra, India.
Int J Nanomedicine. 2019 Mar 7;14:1753-1777. doi: 10.2147/IJN.S176013. eCollection 2019.
Diabetic nephropathy (DN), an end-stage renal disorder, has posed a menace to humankind globally, because of its complex nature and poorly understandable intricate mechanism. In recent times, functional foods as potential health benefits have been gaining attention of consumers and researchers alike. Rich in antioxidants, the peel and seed of pomegranate have previously demonstrated protection against oxidative-stress-related diseases, including cardiovascular disorders, diabetes, and cancer.
This study was designed to investigate the ameliorative role of pomegranate peel extract-stabilized gold nanoparticle (PPE-AuNP) on streptozotocin (STZ)-induced DN in an experimental murine model.
Following the reduction methods, AuNP was prepared using the pomegranate peel ellagitannins and characterized by particle size, physical appearance, and morphological architecture. Modulatory potential of PPE-AuNP was examined through the plethora of biochemical and high throughput techniques, flow cytometry, immunoblotting, and immunofluorescence.
The animals treated with PPE-AuNP markedly reduced the fasting blood glucose, renal toxicity indices, and serum TC and TG in a hyperglycemic condition. As evident from an increased level of plasma insulin level, PPE-AuNP normalized the STZ-induced pancreatic β-cell dysfunction. The STZ-mediated suppression of endogenous antioxidant response was restored by the PPE-AuNP treatment, which reduced the generation of LPO as well as iROS. Furthermore, the hyperglycemia-mediated augmentation of protein glycation, followed by the NOX4/p-47 activation, diminished with the application of PPE-AuNP. The histological and immunohistochemical findings showed the protective efficacy of PPE-AuNP in reducing STZ-induced glomerular sclerosis and renal fibrosis. In addition, it reduced proinflammatory burden through the modulation of the MAPK/NF-κB/STAT3/cytokine axis. Simultaneously, PI3K/AKT-guided Nrf2 activation was evident upon the PPE-AuNP application, which enhanced the antioxidant response and maintained hyperglycemic homeostasis.
The findings indicate that the use of PPE-AuNPs might act as an economic therapeutic remedy for alleviating DN.
糖尿病肾病(DN)是一种终末期肾脏疾病,由于其复杂性和复杂机制难以理解,在全球范围内对人类构成了威胁。近年来,具有潜在健康益处的功能性食品引起了消费者和研究人员的关注。石榴皮和种子富含抗氧化剂,先前已证明它们具有预防与氧化应激相关的疾病的作用,包括心血管疾病、糖尿病和癌症。
本研究旨在探讨石榴皮提取物稳定的金纳米颗粒(PPE-AuNP)对实验性糖尿病肾病(DN)小鼠模型中 STZ 诱导的 DN 的改善作用。
采用还原法,以石榴皮鞣花单宁为原料制备 AuNP,并通过粒径、物理外观和形态结构进行表征。通过多种生化和高通量技术、流式细胞术、免疫印迹和免疫荧光检测 PPE-AuNP 的调节潜力。
用 PPE-AuNP 治疗的动物在高血糖条件下明显降低空腹血糖、肾毒性指数以及血清 TC 和 TG。从血浆胰岛素水平升高可知,PPE-AuNP 可使 STZ 诱导的胰岛β细胞功能障碍正常化。PPE-AuNP 治疗可恢复 STZ 介导的内源性抗氧化反应抑制,降低 LPO 和 iROS 的产生。此外,PPE-AuNP 可减少由高血糖引起的蛋白质糖基化增加,随后减少 NOX4/p-47 的激活。组织学和免疫组织化学结果表明 PPE-AuNP 可通过减少 STZ 诱导的肾小球硬化和肾纤维化来发挥保护作用。此外,它通过调节 MAPK/NF-κB/STAT3/细胞因子轴减少促炎负担。同时,PPE-AuNP 应用后可观察到 PI3K/AKT 指导的 Nrf2 激活,增强抗氧化反应并维持高血糖稳态。
研究结果表明,使用 PPE-AuNPs 可能是一种经济有效的治疗方法,可缓解糖尿病肾病。